1. Luque Paz, Damien, Kralovics, Robert, Skoda, Radek C. . Genetic basis and molecular profiling in myeloproliferative neoplasms. In Blood, 141, 1909-1921. doi:10.1182/blood.2022017578. https://pubmed.ncbi.nlm.nih.gov/36347013/
2. Turro, Ernest, Astle, William J, Megy, Karyn, Raymond, F Lucy, Ouwehand, Willem H. 2020. Whole-genome sequencing of patients with rare diseases in a national health system. In Nature, 583, 96-102. doi:10.1038/s41586-020-2434-2. https://pubmed.ncbi.nlm.nih.gov/32581362/
3. Klampfl, Thorsten, Gisslinger, Heinz, Harutyunyan, Ashot S, Cazzola, Mario, Kralovics, Robert. 2013. Somatic mutations of calreticulin in myeloproliferative neoplasms. In The New England journal of medicine, 369, 2379-90. doi:10.1056/NEJMoa1311347. https://pubmed.ncbi.nlm.nih.gov/24325356/
4. Furuya, Chiho, Hashimoto, Yoshinori, Morishita, Soji, Ando, Miki, Komatsu, Norio. . MPL gene mutation is a possible risk factor for thrombosis in patients with essential thrombocythemia in Japan. In Hematology (Amsterdam, Netherlands), 28, 2229131. doi:10.1080/16078454.2023.2229131. https://pubmed.ncbi.nlm.nih.gov/37378567/